ProMIS Neurosciences EV/Sales
What is the EV/Sales of ProMIS Neurosciences?
The EV/Sales of ProMIS Neurosciences, Inc. is 4,167.21
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on OTC compared to ProMIS Neurosciences
What does ProMIS Neurosciences do?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Companies with ev/sales similar to ProMIS Neurosciences
- Myanmar Metals has EV/Sales of 3,985.42
- ProMIS Neurosciences has EV/Sales of 4,062.08
- Nextpoint Acquisition Corp has EV/Sales of 4,100.12
- Aziana has EV/Sales of 4,130.51
- Fortune Minerals has EV/Sales of 4,164.05
- ObsEva SA has EV/Sales of 4,164.73
- ProMIS Neurosciences has EV/Sales of 4,167.21
- Keros Therapeutics has EV/Sales of 4,170.49
- Avenira has EV/Sales of 4,205.78
- Paradigm Biopharmaceuticals has EV/Sales of 4,219.73
- Hexa Tradex has EV/Sales of 4,367.43
- Societe d'Exploration Miniere Vior has EV/Sales of 4,394.04
- Nextpoint Inc has EV/Sales of 4,422.20